Company intelligence / Profile preview

EntheoTech Bioscience

Kelowna, British Columbia, Canada

Ownership: Private
Employees: ~15
Development stage: Other

Overview

EntheoTech Bioscience is a Canadian biotechnology and healthcare company specializing in the research and delivery of psychedelic-assisted therapies. The company operates through three primary pillars: bioscience research, clinical services via its EntheoMed clinics, and a focus on mental health and chronic pain management. EntheoTech is dedicated to the genetic profiling and cultivation of psilocybin mushrooms to create standardized, pharmaceutical-grade formulations for therapeutic use. By integrating interventional psychiatry with psychedelic research, the company aims to provide innovative solutions for treatment-resistant depression, PTSD, and complex pain conditions.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on EntheoTech Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EntheoTech Bioscience.

Explore the full profile